drugset / Trial / NCT06809816
Efficacy of OsteoBor in Postmenopausal Osteoporosis
RandomizedParallel-groupDouble-blindTreatment
Summary
This study aims to evaluate the impact of boron supplementation (OsteoBor) on bone health in postmenopausal women. The trial is a phase 2, randomised, double-blind, placebo-controlled study lasting one year
Timeline
- Start
- 2025-03-01
- Primary completion
- 2025-08-01
- Completion
- 2025-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PENTABORATE | Small molecule | 1000 mg | Oral |